ISSN : 1300-6045
E-ISSN : 1309-2251

14th EASE Conference, Bucharest 2018

The 14th EASE Conference will be held in Bucharest, Romania, 8th-10th June, 2018. The theme for the event will be ‘Balancing Innovation and Tradition in Science Editing’. The theme is relevant to editors in Eastern Europe and the Balkans, but also to editors anywhere working independently or in small offices.

 

Source: http://www.ease.org.uk/ease-events/14th-ease-conference-bucharest-2018/

European Medicines Agency (EMA) launches a survey that assesses awareness of patients and doctors about arrangements for reporting of side effects

The European Medicines Agency (EMA) has launched a survey. The objective of the survey is to assess the awareness, attitudes and reporting behaviors of patients and healthcare professionals to report adverse drug reactions, including for medicines under ‘additional monitoring’.

The questionnaire is available in all official European Union languages. It will be open for responses until 9 October 2017. EMA and the European Commission will analyze the results of the survey and the conclusions will be published in 2018.

Source:http://www.ema.europa.eu/ema/index.jsp?curl=pages/news_and_events/news/2017/09/news_detail_002807.jsp&mid=WC0b01ac058004d5c1

A recent mouse study at the UC Davis School of Veterinary Medicine demonstrated that a high-fat, or ketogenic, diet not only increases longevity, but improves physical strength.

 

Jon Ramsey, senior author of the article in Cell Metabolism (September 2017), said “We expected some differences, but I was impressed by the magnitude we observed — a 13 percent increase in median life span for the mice on a high-fat versus high-carb diet. In humans, that would be seven to 10 years. But equally important, those mice retained quality of health in later life.”

Source: https://www.ucdavis.edu/news/eat-fat-live-longer

http://www.cell.com/cell-metabolism/fulltext/S1550-4131(17)30490-4

American Institute for Cancer Research (AICR) and World Cancer Research Fund (WCRF) reported that eating whole grains daily, such as brown rice or whole-wheat bread, reduces colorectal cancer risk, with the more you eat the lower the risk.

 

Diet, Nutrition, Physical Activity and Colorectal Cancer also found that the risk of colorectal cancers increases with regular consumption of hot dogs, bacon and other processed meats. A strong evidence that physical activity protects against colon cancer exists.

The report is part of the Continuous Update Project (CUP). This project is an ongoing analysis of the global research on how diet, nutrition, physical activity and weight affect cancer risk and survival.

Source: http://www.aicr.org/press/press-releases/2017/new-report-whole-grains-link-to-lower-colorectal-cancer-risk-for-first-time.html

First International Health Sciences Congress will be held in Balkan Congress Center, Edirne on 23-25 November 2017.

Congress website: http://atuc2017-en.trakya.edu.tr

 

CAR T-cell therapy approved to treat certain children and young adults with B-cell acute lymphoblastic leukemia

The U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel), a cell-based gene therapy, for certain pediatric and young adult patients with a form of acute lymphoblastic leukemia (ALL).

 

Kymriah is a genetically-modified autologous T-cell immunotherapy. The patient’s T-cells are collected and genetically modified. The genetically-modified T-cells have a new gene that contains a specific protein (a chimeric antigen receptor or CAR) that directs the T-cells to target and kill leukemia cells that have a specific antigen (CD19) on the surface. These cells are given back to the patient to kill the cancer cells.

Source: https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm574058.htm

A Danish nationwide register-based cohort study

In a BMJ article, Xiaoqin Liu and colleagues reported that in utero exposure to antidepressants was associated with increased risk of psychiatric disorders. Using Danish registries, researchers followed over 900,000 children born between 1998 and 2002.

 

The adjusted 15-year cumulative incidence of psychiatric disorders was 0.8% in unexposed children, 11.5% in the antidepressant discontinuation group (antidepressant use before but not during pregnancy), and 13.6% in the antidepressant continuation group (antidepressant use both before and during pregnancy) and new user (antidepressant use only during pregnancy).

The researchers noted that the associations "may be attributable to the severity of underlying maternal disorders in combination with antidepressant exposure in utero." They also said that "Our results do not confirm causality."

Source: http://www.bmj.com/content/358/bmj.j3668